Comparison of Hemoglobin Concentration Adjusted for Altitude and Serum Iron and Ferritin to Diagnose Anemia in Childhood in Highlands

Blood ◽  
2016 ◽  
Vol 128 (22) ◽  
pp. 2459-2459 ◽  
Author(s):  
Ximena Robalino ◽  
Mercedes Balladares-Saltos ◽  
Patricia Miño ◽  
Marcela Guerendiain

Abstract Introduction: Iron deficiency anemia in childhood is a public health problem, especially in developing countries, being one of the most prevalent nutritional disorders in Ecuador. The proper diagnosis of anemia at school age is a priority, because it is related to inadequate growth and cognitive development, low immunity and increased morbidity and mortality. In highlands, the anemia diagnosis is difficult due to hyperbaric hypoxia stimulates erythropoiesis and the low sensitivity of conventional methods. It was established that hemoglobin concentration increases with altitude, proposing that these values must be adjusted for the altitude of residence. Thus, different models were generated to correct hemoglobin. However, other authors have an opposite position, stating that the adjustment is not required. It should be noted that, unlike hemoglobin, the content of body ferritin is not affected by the elevation above sea level, therefore constitutes an alternative for the assessment of anemia in highlands. Hence, our objective was to evaluate different hematological parameters, including the hemoglobin correction, to diagnose anemia in children living in regions of high geographical altitude, in Ecuador. Methods: This study has been carried out in San Juan and Yaruquíes schools, located at 3240 and 2764 meters above sea level, respectively. It was included 140 preschool and school children, who participated in the EVANES study, aged 3 to 13 years old. The 60% were female. Serum iron and ferritin and hemoglobin and hematocrit concentrations were measured in blood. The hemoglobin was evaluated considering the uncorrected values and the concentration adjusted for the geographical altitude of each region, according to World Health Organization (WHO), Center for Disease Control (CDC; for children), Dirren (for children) and Cohen (for pregnant women) methods. Children with hemoglobin levels lower than 11.5 g/dl were considered anemic (n=18/16/18/12; WHO, CDC, Dirren et al and Cohen et al, respectively). This study was conducted in accordance to the ethical rules of the Helsinki Declaration and the current Ecuadorian law, which regulates clinical research on humans, and was approved by the Ethic Committee of the San Francisco de Quito University. Written informed consent was obtained from all schoolchildren parents or tutors. Results: The means of age, hematocrit, unadjusted hemoglobin, serum iron and ferritin were: 8.65 ± 2.16 years, 43.01 ± 2.66 %, 14.27 ± 0.90 g/dl, 14.28 ± 4.04 µmol/l and 30.95 ± 14.33 ng/ml, respectively. When the correction factors and equations were applied, the hemoglobin concentrations were 12.45 ± 0.88 g/dl (WHO), 12.54 ± 0.88 g/dl (CDC), 12.43 ± 0.88 g/dl (Dirren) and 12.73 ± 0.89 g/dl (Cohen). No differences between female and male were found in hematological parameters. According to unadjusted hemoglobin, no cases of anemia were determined. By applying the corrections, 13.5% (WHO), 12.0% (CDC), 13.5% (Dirren) and 9.0% (Cohen) of children were identified as anemic, and using serum ferritin and iron the percentages were 10.3% and 15.0%, respectively. When comparing the latters with the corrected hemoglobin, there were no differences in the frequency of anemia. However, of the 14 children assessed as anemic using ferritin, only 2 (0MS), 1 (CDC), 2 (Dirren) and 1 (Cohen) of them presented this condition applying the adjusted hemoglobin, and 11 to 16 non-anemic children were classified as anemic. On the other hand, taking into account adjusted hemoglobin, there were more cases of anemia among boys than girls (p<0.05), but considering the ferritin and iron, no differences were found between sexes. In relation to the adjusted hemoglobin (all methods), the children identified as anemic presented lower hematocrit and hemoglobin (uncorrected and adjusted) levels (p<0.001) than non-anemic. No differences were found between groups in ferritin and iron concentration. Conversely, when ferritin and iron were used to divide the children, only these parameters were different in anemic and non-anemic groups (p<0.001). Conclusions: According to our findings, the adjustment of hemoglobin concentration by geographical altitude may be an useful method to diagnose anemia in childhood at the population level but not individually. Serum ferritin is the most appropriate anemia indicator for the individual assessment in children living in highlands. Disclosures No relevant conflicts of interest to declare.

2020 ◽  
Vol 11 (2) ◽  
pp. 43-50
Author(s):  
Tatiana I. Tsidaeva ◽  
Kristina G. Tomaeva ◽  
Sergey N. Gaidukov ◽  
Nikolai N. Rukhliada ◽  
Aida A. Cheldieva ◽  
...  

The aim of the study: to study the frequency of anemia in pregnant women with different somatotypes and to develop a model for predicting the risk of this pathology. Materials and methods. 390 women were examined. Of the women studied 110 were mаcrosomatotype, 173 mesosomatotype, and 107 microsomatotype. Somatometry was performed according to R.N. Dorokhov for women in early pregnancy (before 910 weeks of gestation). In blood test the level of hemoglobin, red blood cells, and hematocrit is determined using the Medonic M-series hematological automatic analyzer. Serum iron levels were determined colorimetrically with ferrosine. Serum ferritin levels were determined spectrophotometrically using ELISA methods. Results. It was found that iron deficiency anemia was significantly more common in pregnant women of macro-and microsomatic body type compared to women with mesosomatotypes (p 0.05). Pregnant women with severe anemia were not found. There were iron deficiency anemia of mild and moderate severity, and latent iron deficiency. Hematological parameters (hematocrit, serum iron, serum ferritin) were significantly lower in pregnant women with latent iron deficiency compared to women without anemia (p 0.05). Using multiple regression analysis, we obtained the regression equation (formula), which predicts the development of iron deficiency anemia in pregnant women of different somatotypes. Conclusions. The calculations according to the presented formula, allows to predict with high accuracy the prognosis of iron deficiency anemia in pregnant women, and also allows to form among patients a high-risk group for the development of this disease in the first trimester of pregnancy when the pregnant woman is registered in the womens consultation, which will contribute to more effective implementation of therapeutic and preventive measures to prevent the development of this pathology.


2020 ◽  
Vol 2020 ◽  
pp. 1-6
Author(s):  
Fernanda Cozendey Anselmo ◽  
Natália Santos Ferreira ◽  
Adolfo José da Mota ◽  
Marilda de Souza Gonçalves ◽  
Sérgio Roberto Lopes Albuquerque ◽  
...  

Alpha-thalassemia is highly prevalent in the plural society of Brazil and is a public health problem. There is limited knowledge on its accurate frequency and distribution in the Amazon region. Knowing the frequency of thalassemia and the prevalence of responsible mutations is, therefore, an important step in the understanding and control program. Hematological and molecular data, in addition to serum iron and serum ferritin, from 989 unrelated first-time blood donors from Amazonas Hemotherapy and Hematology Foundation (FHEMOAM) were collected. In this study, the subjects were screened for −α3.7/4.2/20.5, −SEA, −FIL, and −MED deletions. Alpha-thalassemia screening was carried out between 2016 and 2017 among 714 (72.1%) male and 275 (27.9%) female donors. The aims of this analysis were to describe the distribution of various alpha-thalassemia alleles by gender, along with their genotypic interactions, and to illustrate the hematological changes associated with each phenotype. Amongst the patients, 5.35% (n = 53) were diagnosed with deletion –α−3.7 and only one donor with α−4.2 deletion. From the individuals with –α−3.7, 85.8% (n = 46) were heterozygous and 14.20% (n = 7) were homozygous. The frequency of the –α−3.7 deletion was higher in male (5.89%) than in female (4.0%). There is no significant difference in the distribution of –α−3.7 by gender (p=0.217). The –α20.5, −SEA, and −MED deletions were not found. All subjects were analyzed for serum iron and serum ferritin, with 1.04% being iron deficient (n = 5) and none with very high levels of stored iron (>220 µg/dL). Alpha-thalassemia-23.7kb deletion was the most common allele detected in Manaus blood donors, which is a consistent result, once it is the most common type of α-thalassemia found throughout the world. As expected, the mean of hematological data was significantly lower in alpha-thalassemia carriers (p<0.001), mainly homozygous genotype. Leukocytes and platelet count did not differ significantly. Due to the small number of individuals with iron deficiency found among blood donors, the differential diagnosis between the two types of anemia was not possible, even because minor changes were found among hematological parameters with iron deficiency and α-thalassemia. Despite this, the study showed the values of hematological parameters, especially MCV and MCH, are lower in donors with iron deficiency, especially when associated with α-thalassemia, and therefore, it may be useful to discriminate different types of microcytic anaemia. In conclusion, we believed screening for thalassemia trait should be included as part of a standard blood testing before blood donation. It should be noted that this was the first study to perform the screening for alpha deletions in blood donors from the Manaus region, and further studies are required to look at the effects of donated thalassemic blood.


Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 5173-5173
Author(s):  
Pankaj Malhotra ◽  
Basavaraj GS ◽  
Naresh Sachdeva ◽  
Jasmina Ahluwalia ◽  
Sanjay Bhadada

Abstract Abstract 5173 Background: The effect of vitamin D replacement on hemoglobin concentration in subjects with concurrent iron deficiency anemia and vitamin D deficiency is not known. Methods: In a single blinded randomized placebo controlled study, thirty subjects with iron deficiency anemia (serum ferritin < 15 ug/dl) were randomized to intervention arm (vitamin D 6 lakh IU IM once) or placebo. In all subjects, iron deficiency was corrected with parental iron. All the causes other than iron deficiency were excluded with appropriate investigation. The primary end point was rise in hemoglobin concentration. Results: Baseline age, BMI, hemogram, levels of serum ferritin, 25(OH)D and PTH were similar in both the arms. Twelve weeks after vitamin D replacement, there was significant increase in 25 (OH) D levels and decrease in PTH levels in subjects with intervention arm compared to placebo arm (p<0. 01). The increment in serum ferritin in both the group was similar. There was no further increase in hemoglobin concentration in intervention arm compared to placebo arm. Conclusion: Vitamin D replacement in subjects with iron deficiency anemia after iron correction does not improve hemoglobin concentration further. Disclosures: No relevant conflicts of interest to declare.


Author(s):  
Sajjad H. Naqvi ◽  
Syed Faizan-ul-Hassan Naqvi ◽  
Iftikhar H. Naqvi ◽  
Muhammad Farhan ◽  
Tanveer Abbas ◽  
...  

PEDIATRICS ◽  
1981 ◽  
Vol 68 (3) ◽  
pp. 397-400
Author(s):  
Yehezkel Naveh ◽  
Anna Hazani ◽  
Moshe Berant

A 6-month-old full-term infant had severe anemia and neutropenia. The patient was being fed cow's milk and a diet of corn flour. Thorough investigation revealed low serum iron concentration, severe hypocupremia, low ceruloplasmin, retardation of bone age, and metaphysial irregularities and spurring. Bone marrow aspirate revealed cytoplasmic vacuolization in precursors of the erythroid and myeloid series and ringed sideroblasts. Therapy with oral iron, folic acid, and vitamin C was futile. Administration of copper sulfate resulted in brisk increase in neutrophils and reticulocytes. The child maintained normal levels of hemoglobin, neutrophils, serum copper and ceruloplasmin, and serum iron one year after copper therapy was discontinued. The probable role of unrecognized copper deficiency in causing anemia in infants more than 6 months of age is discussed, and the importance of serum copper examination in refractory iron deficiency anemia and neutropenia is stressed. To the best of our knowledge, no such case has previously been described in the literature.


2020 ◽  
Author(s):  
Alexia Degremont ◽  
Rishika Jain ◽  
Elena Philippou ◽  
Gladys Oluyemisi Latunde-Dada

Abstract Context Attention deficit/hyperactivity disorder (ADHD) is a neurological disorder associated with iron dysregulation in children. Although previous focus was on examining systemic iron status, brain iron content may be a more reliable biomarker of the disorder. Objective This systematic review examines whether children with ADHD have lower serum as well as brain iron concentrations, compared with healthy control subjects (HCS). Data sources A systematic literature search was conducted in Medline via PubMed, the Cochrane Library, Web of Science, Embase. and Ovid for papers published between 2000 and June 7, 2019. Data extraction Studies were included if the mean difference of iron concentration, measured as serum iron, serum ferritin, or brain iron, between children with ADHD and HCS was an outcome measure. Data analysis Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. Risks of bias within and between studies were assessed using the quality assessment tools of the National Institutes of Health. Of 599 records screened, 20 case-control studies met the inclusion criteria. In 10 of 18 studies in which serum ferritin concentration was assessed, and 2 of 10 studies that assessed serum iron, a significant difference between children with ADHD and HCS was observed. Results of systemic iron levels were inconsistent. In 3 studies in which brain iron concentration was assessed, a statistically significant, lower thalamic iron concentration was found in children with ADHD than in HCS. Conclusion The evidence, though limited, reveals that brain iron rather than systemic iron levels may be more associated with the pathophysiology of ADHD in children. Larger, longitudinal, magnetic resonance imaging studies are needed to examine any correlations of iron deficiency in specific brain regions and symptoms of ADHD.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Gorkem Sezgin ◽  
Paul Monagle ◽  
Tze Ping Loh ◽  
Vera Ignjatovic ◽  
Monsurul Hoq ◽  
...  

Abstract Low serum ferritin is diagnostic of iron deficiency, yet its published lower cut-off values are highly variable, particularly for pediatric populations. Lower cut-off values are commonly reported as 2.5th percentiles, and is based on the variation of ferritin values in the population. Our objective was to determine whether a functional approach based on iron deficient erythropoiesis could provide a better alternative. Utilizing 64,443 ferritin test results from pediatric electronic health records, we conducted various statistical techniques to derive 2.5th percentiles, and also derived functional reference limits through the association between ferritin and erythrocyte parameters: hemoglobin, mean corpuscular volume, mean cell hemoglobin concentration, and red cell distribution width. We find that lower limits of reference intervals derived as centiles are too low for clinical interpretation. Functional limits indicate iron deficiency anemia starts to occur when ferritin levels reach 10 µg/L, and are largely similar between genders and age groups. In comparison, centiles (2.5%) presented with lower limits overall, with varying levels depending on age and gender. Functionally-derived limits better reflects the underlying physiology of a patient, and may provide a basis for deriving a threshold related to treatment of iron deficiency and any other biomarker with functional outcomes.


1958 ◽  
Vol 193 (1) ◽  
pp. 92-94
Author(s):  
Alfred Chanutin

The administration of sublethal doses of bone marrow depressants (nitrogen mustard, triethylene melamine and thioguanine) causes a temporary, moderate increase in serum iron concentration, a slight depression of bone marrow activity and no change in hemoglobin concentration. A combination of any of these drugs with a small dose of phenylhydrazine causes a temporary marked hyperferremia, a moderate anemia and a marked reticulocytosis. The results indicate that hyperferremia is not necessarily associated with bone marrow activity.


Author(s):  
Mauro Buttarello ◽  
Rachele Pajola ◽  
Enrica Novello ◽  
Giacomo Mezzapelle ◽  
Mario Plebani

AbstractBackground:Iron deficiency represents the most frequent cause of anemia. To diagnose iron deficiency some biochemical tests such as serum ferritin and the transferring saturation percent (TSAT%) are usually used. Recently, some hematological parameters such as mean reticulocyte hemoglobin content (CHr or Ret-He) and percentage of hypochromic RBCs (Hypo% or %Hypo-He) were proposed as alternative to biochemical tests. In this study, the analytic performance and the diagnostic efficiency of these two parameters provided by Sysmex XE5000 analyzer on iron deficiency patients with or without anemia (IDA and ID, respectively) were evaluated.Methods:One hundred and sixty-four healthy adults, 58 with IDA, 21 with iron depleted stores (ID), 23 with β-thalassemia trait, and 24 with non iron deficiency anemia were selected. The gold standard used to define iron deficiency was the coexistence of serum ferritin below 15 μg/L (12 in women) and TSAT <16%.Results:For %Hypo-He, the best cut-off value for both IDA and ID is 0.9% while for Ret-He is 30.6 pg. For both parameters the performance was better to diagnose IDA (AUC, 0.96 and 0.98) than ID (AUC, 0.93 and 0.95). The Ret-He behavior was always slightly better than that of %Hypo-He.Conclusions:The use of these two parameters is useful to detect iron deficiency conditions if the hemoglobin synthesis has already been compromised.


Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 3210-3210
Author(s):  
Arun S. Shet ◽  
Sneha Pinto ◽  
Gopa Mitra ◽  
Pooja Subramaniam ◽  
Amit Mandal

Abstract Abstract 3210 Introduction: Iron deficiency anemia (IDA) is a major health problem worldwide. Although a clinical diagnosis is relatively simple, specific laboratory markers of IDA are lacking especially in the setting of inflammation. Ferritin, the current standard to define IDA is an acute phase protein that is non-specifically elevated during inflammation. Serum transferrin receptor level measurements although available are not yet standardized as a clinical tool. Serum hepcidin is a recently developed novel marker that is currently neither available nor standardized sufficiently. Furthermore, such assays require instrumentation, technical sophistication, and are expensive. Objectives: We sought to identify novel markers of IDA using mass spectrometry based proteomics. Identifying such markers could yield targets that once validated could serve cost effective point of care assays to detect iron deficiency anemia. Since there is evidence for oxidative damage mediated by reactive oxygen species in IDA, as a first step, we characterized and quantified posttranslational oxidative modifications of hemoglobin and tested their utility as biomarkers. Patients and Methods: We prospectively enrolled patients with IDA (defined as ferritin <12ng/ml in the presence of normal CRP and/or a bone marrow aspirate with “0” iron stores) and healthy controls (n = 23 and 15 respectively). Patients with diabetes, cardiovascular disease, renal disease, cerebrovascular disease and liver disease were excluded as these are conditions associated with preexisting oxidant stress. Erythrocytes from the blood of IDA patients and controls were isolated by centrifugation, washed in 0.9% saline, and lysed in distilled water to yield intracellular hemoglobin. Hemoglobin was then either studied further as an intact molecule or after digestion with trypsin. We used matrix assisted laser desorption ionization (MALDI - TOF) mass spectrometry to identify oxidative modifications of tryptic digested hemoglobin. We used electro spray ionization (ESI) mass spectrometry to identify and semiquantitate oxidative hemoglobin modifications by methods previously established and published by others and ourselves. Results: Using a combination of mass spectrometric methods, we identified 4 oxidative modifications of hemoglobin in patients with IDA and healthy controls (Table 1). Interestingly, a non enzymatic posttranslational modification of hemoglobin, glutathionyl hemoglobin, was found to be significantly increased in IDA patients compared with healthy controls (Glutathionyl hemoglobin % of beta chain; mean ± SD 0.169 ± 0.096 vs 0.077 ± 0.037; p = 0.001). Markers of oxidative stress (reduced RBC glutathione) were lower in IDA compared to healthy controls but the difference was not significant (mean ± SD 0.92 ± 0.53 vs 1.08 ± 0.52 mmol/L; p = 0.54). Glutathionyl hemoglobin levels correlated inversely with serum ferritin (Spearman rho -0.485; p < 0.05). Conclusions: Using two distinct proteomic methods, we identified oxidative posttranslational modifications of hemoglobin in IDA and healthy controls. Glutathionyl hemoglobin, an established marker of oxidative stress was elevated in patients with IDA and correlated inversely with serum ferritin. Overall, these findings suggest that glutathionyl hemoglobin has potential as a biomarker of IDA. Disclosures: No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document